Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Consultant Clinical or Medical Oncologist: Lower GI Cancer Christie Hospital NHS Foundation Trust JOB DESCRIPTION Contents Page A) Christie Hospital NHS Foundation Trust 2 B) University of Manchester: Cancer Studies 2 C) Department of Clinical Oncology 3 D) CRUK Department of Medical Oncology 4 E) Associated Departments 5 F) Gastro–Intestinal Disease Orientated Group 7 G) Proposed Appointment 7 H) Indicative Timetable 9 I) Duties of the Post 9 J) Person Specification 11 K) Informal Visits 12 Appendix 1: Clinical Oncology Consultants 13 Appendix 2: Medical Oncology Consultants 14 New Posts: job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008 1 A) Christie Hospital NHS Foundation Trust Situated in a pleasant suburb, some 3 miles from Manchester city centre, the Christie Hospital and Holt Radium Institute was founded in 1932 and has grown to be the largest Cancer Hospital in the UK and one of the largest Cancer Centres in Europe covering a large population in North West England. In addition to the Christie Hospital itself, the Trust also comprises the North Western Medical Physics Department, one of the largest of its kind in the UK, and the Paterson Institute for Cancer Research, funded by Cancer Research UK. The Hospital is a designated teaching hospital of the University of Manchester and is a focal point of the Greater Manchester and Cheshire Cancer Network. All cancer-related specialties are fully operational and over 12,000 new patients with cancer are seen each year. The Christie site is the focal point of the recently established Manchester Cancer Research Centre. The Christie Hospital is composed of three clinical management divisions Networked Services Division – Director Dr Wendy Makin – includes the Departments of Medical Oncology, Clinical Oncology, Palliative Care, Paediatric and Adolescent Oncology Cancer Centre Services – Director Miss Sarah O’Dwyer - Surgery, Anaesthetics, Haematology, HDU, Endocrinology Clinical Support Services – Director Dr Jeremy Lawrance - Radiology, Pathology. Other support services are provided by the Divisions of Finance, Nursing & Operations and Estates and Facilities. Both the Departments of Medical Oncology (Director: Dr Michael Leahy) and Clinical Oncology (Director: Dr Nick Slevin), have international reputations for their clinical work. All consultants are site specialised and common treatment policies are developed through the multi-disciplinary Disease Oriented Groups (DOGs). Links to the cancer units are maintained through a number of peripheral and outreach clinics across the network. There are plans for the Christie to develop satellite centre’s at the Pennine Acute Trust and at Salford Royal Hospital Trust so that ambulatory can be can be delivered more locally. The Christie Hospital NHS Foundation Trust is committed to cancer research and there was a successful Centenary Appeal that raised £25m for development of work at the Christie. Amongst other projects it is planned that £1m will go to an innovative treatment centre, £3m to the development of a Molecular Diagnostics Unit, which has already commenced, and £3.5m for the development of a Gene Therapy Centre. These, along with other developments, will further enhance the research standing of the Trust. The present Executive Directors of the Trust are: Caroline Shaw Ian Moston Dr Ron Stout Dr Chris Harrison Alison Norman Roger Spencer B) - Chief Executive Executive Director of Finance & Performance Medical Executive Director (Internal) Medical Director (External) Executive Director of Nursing & Governance Chief Operating Officer University of Manchester: Cancer Studies Cancer Studies at the University of Manchester (Group Leader: Professor A Freemont) comprises a number of research groupings including the CRUK Department of Medical Oncology, Cancer Epidemiology and the Academic Department of Radiation Oncology. There are close links with the Paterson Institute for Cancer Research and a number of New Posts: job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008 2 the Institute’s senior staff have honorary University posts within Cancer Studies which was rated 5* in the 2001 Research Assessment Exercise (RAE). The major grouping within Cancer Studies is the CRUK Department of Medical Oncology that is one of the largest in the country. The department has laboratories located within the Paterson Institute and annual grant support of about £2m per annum from the CRUK, the Kay Kendall Leukaemia Fund, AICR, BBSRC, EU and others. There is a wide range of clinical and laboratory research within the Department. The appointment of Professor Hawkins as CRUK Professor of Medical Oncology has led to an expansion of translational research activity particularly in the field of gene and immunotherapy, with a focus on gastrointestinal cancer. Overall, the areas of laboratory research within Medical Oncology comprise: growth factors and glycobiology (Professor J Gallagher, Professor G Jayson), breast biology (Professor A Howell and Dr Rob Clark), immunology and cancer vaccines (Professor R Hawkins closely linked with Professor P Stern), gene therapy (Professor R Hawkins and Dr D Gilham). The Hospital has a Statistics Department, directed by Mr. R Swindell, which offers support to clinicians involved in clinical studies and trials. In addition to the above links there are close links with groups in the Paterson Institute. The Paterson is a major Cancer Research UK Institute with £8M per year grant support and a broad range of basic and translational research. The research groups include: Bioinformatics - Crispin Miller Carcinogenesis -Geoff Margison Cell Division - Iain Hagan Cell Regulation - Nic Jones Cellular and Molecular Pharmacology - Caroline Dive Cell Signaling - Angeliki Malliri Functional Genomics and Cell Cycle Regulation - Karim Labib Immunology - Peter L. Stern Radiochemical Targeting and Imaging - Jamal Zweit Stem Cell Biology - Georges Lacaud Stem Cell and Haematopoiesis - Valerie Kouskoff Structural Cell Biology - Terry Allen The institute has excellent central services including molecular biology (sequencing, realtime PCR, Affymetrix Micro array), FACs analysis and sorting, image analysis and pharmacology. Pat Price (Professor of Radiation Oncology) is developing a major new Molecular Imaging Centre for translational studies which will provide state-of-the-art PET scanning facilities. The design of this £8m building is the most advanced centre of its kind internationally. Together with the large Oncology practice, extensive CRUK Phase I activities and the Paterson Institute it will facilitate mechanistic trials of novel agents. C) Department of Clinical Oncology The Department of Clinical Oncology presently provides a service to Greater Manchester and Cheshire, and parts of Lancashire, through regular clinics (mainly weekly), staffed by its consultants (see appendix 1). The population of the Hospital’s catchment area is approximately 3.2 million. A total of 11,000 new patients with cancer were seen by the hospital and associated clinics in 2006. In 2006, 8,000 patients were treated with radiotherapy. We have close links with the Rosemere Cancer Centre at Preston. New Posts: job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008 3 The Radiotherapy Department has eleven service linear accelerators, a research linac suite (Wade Centre), and a Pantak superficial x-ray therapy unit. Two of the linacs are Elekta Synergy linacs with facilities for image guided radiotherapy. There are three simulators, 2 with CT attachments, one with cone beam imaging and an application for a CT-Sim is ongoing. There is an ADAC Pinnacle computerised treatment planning system. IMRT for prostate cancer has been in use for several years. There are plans to develop Satellite Radiotherapy facilities over the next 3 years away from the Withington site. These are most likely in the first place to be built at a site in the north of the conurbation. The successful candidate would not be expected to take a role in supervising treatments at this satellite unit though additional units are planned in other areas of the Network. There is a purpose built, Radiotherapy Theatre housing a high dose rate microselectron. Adjacent to one ward is a low dose rate Selectron remote afterloading suite for Gynaecological patients. There is a fully equipped Mould Room. Facilities are present for interstitial therapy (including prostate brachytherapy) and manually afterloaded brachytherapy. In 2006 approximately 200 permanent Iodine 125 seed implants were conducted. A business case to develop HDR brachytherapy is in place and treatment of patients will begin in 2007/08. The Isotope Department provides facilities for the therapeutic use of I 131, P 32, Sr 89 and Samarium. There are three rooms for the management of patients being treated with unsealed Isotopes. There is a large group of therapeutic radiographers. The hospital is a teaching unit of the University of Liverpool, School of Therapy Radiography. The North West medical physics group is based at the Christie, is directed by Professor Peter Williams and supports the Radiotherapy Department. IMRT has been developed for prostate cancer, breast cancer, head and neck cancer, and will be introduced in other tumour sites in due course. Clinical Staff The medical staff establishment provides for twenty-seven Clinical Oncology Consultants, (see appendix 1) 3 full time academics and fifteen Specialist Registrars in Clinical Oncology. There is a junior doctor team at F2 level, working jointly with medical oncology and haematology, within the Division of Networked Services. D) Department of Medical Oncology The Department of Medical Oncology is now one of the largest departments of cancer medicine in the UK. Dr Michael Leahy is Director of Medical Oncology and the major remit of the department is to develop improved methods for cancer patient management. There are both clinical and laboratory scientific research components that are closely integrated with clinical research and service work. The Department is based at the Christie Cancer Centre (Christie Hospital and Paterson Institute for Cancer Research) with a Breast Cancer Unit at Wythenshawe / Withington Hospital (University Hospitals of South Manchester) and a Thoracic Oncology Unit at Wythenshawe Hospital (Cardiothoracic Centre). More than 2,500 new cancer patients are seen each year by staff in the Department of Medical Oncology. New Posts: job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008 4 The Department has links with Preston Oncology Centre and with the Department of Medical Oncology at Lancaster Royal Infirmary, which is included as part of the Medical Oncology SpR rotation (total 17 NTN’s). Consultant Medical Oncologists at Preston, Lancaster and Blackpool form part of the extended Department and have many common protocols with Manchester. Clinical Staff There are nineteen consultants in the department of Medical Oncology (see appendix 2). There are at present eleven Specialist Registrars, six SHO level posts. Eight Clinical Research Fellows also participate in clinical activities, in addition to their laboratory research. There will be further posts developed as the Foundation programme rolls out. E) Associated Departments Haematological Oncology Dr James Cavet, Dr Effie Liakopoulou , Dr Adrian Bloor and Dr Mike Dennis run a major transplant unit with 18 dedicated beds. Appointment of a Professor and Senior Lecturer are planned shortly. Ward facilities 1. 2. 3. 4. 5. 6. General medical oncology wards – 40 inpatient beds available on modern wards with excellent routine facilities. 16 inpatient chemotherapy beds shared with Clinical Oncology. Used for shorter stay chemotherapy treatments, these beds are not normally open at weekends. The Adult Leukaemia Unit (ALU), with 18 beds available for the care of adult patients with haematological malignancy and lymphoma requiring myeloablative therapy with haemopoietic rescue. Chemotherapy Day Wards (wards 3 and 5). Used for longer day case chemotherapy treatments, with 9 inpatient beds available if necessary. Eight bedded Critical Care Unit. The Christie has a private patient facility (Nathan House) that has 18 rooms. These are primarily for private patients but are made available to NHS patients if the need arises A wide range of cancers are managed in these ward facilities and practical training in all aspects of cancer medicine is provided at SHO/SpR levels. Special facilities include two cell separators for leukapheresis and plasmapheresis. Outpatient facilities Routine medical oncology clinics are held daily at the Christie Hospital for new patients and follow up. There are specialised cancer site related collaborative clinics and routine outpatient clinics. Several of the Consultants visit DGH’s within the Greater Manchester and Cheshire Cancer Network to undertake clinics for new and follow-up patients. We are currently reviewing our outpatient facilities, and the treatment and follow-up appointments, with a view to moving some of the activity to Cancer Units in the network. Specialist nurse facilities Teams of specialist chemotherapy and research nurses work alongside the clinicians. These nurses have special expertise and training in the administration of chemotherapy. Specialist nurses are also trained to insert i.v. long lines, carry out bone marrow New Posts: job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008 5 aspiration/trephine procedures, operate the cell separators for leukapheresis and provide psychological support and counselling. Other departments The Department of Histopathology provides a regional cancer service. The Department of Diagnostic Radiology has two whole body spiral CAT scanners and two MR scanners, in addition to standard radiological and radionucleide imaging facilities. This department is currently undergoing major refurbishment, and will be recommissioned with new and more extensive equipment next year. The Department of Psychological Medicine is involved in collaborative research projects concerning psychological assessment and counselling in the context of clinical trials and is responsible for staff training in aspects of psychological support. Clinical and Laboratory Scientific Research A wide range of clinical research studies are in progress. The breast, lung and GI research groups are major contributors to national and international trials of new treatments. These include Phase I/II and III chemotherapy studies, combined surgery, radiotherapy and chemotherapy studies and patient evaluation studies (staging procedures, psychological assessment etc). A special interest is taken in the development of new biological therapies particularly anti-angiogenic therapies (lead by Professor Gordon Jayson) and gene/immunotherapies (lead by Professor Robert Hawkins). These link laboratory research in the Paterson Institute with early phase clinical trials. The Derek Crowther Unit was opened in 2003 (lead clinician Dr Malcolm Ranson) and provides excellent clinical research facilities for early phase clinical trials. Excellent computer facilities are available within the Medical Oncology Directorate and there is a close association with the Department of Medical Statistics. Data managers are in post to help handle clinical and laboratory research data. Training is given in this important aspect of clinical research. Travel facilities Support is available for participation in research meetings. Administrative facilities The post holder will have office accommodation with computer, intranet and internet access at both sites. There will be secretarial support appointed to support the post. F) Gastro-intestinal Disease Orientated Group The Gastrointestinal DOG also provides comprehensive treatment for GI Cancers and has a broad ranging laboratory and clinical research portfolio. The DOG group covers surgical and non-surgical oncology and the core members (and their primary clinical interest) are: Oncologists Dr Paul Burt – Dr Corinne Finn Prof. Robert Hawkins – New Posts: Oesophageal Radiotherapy Oesophageal Radiotherapy Renal/Oesophago-Gastric systemic therapy Phase I trials of gene/immunotherapy job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008 6 Dr Ed Levine Dr Catherine McBain Dr Vivek Misra Dr Mark Saunders – – – – Dr Juan Valle – Dr Greg Wilson Dr Jurjees Hassan Dr Saifee Mullamitha Dr Was Mansoor Dr Fiona Thistlethwaite Surgeons Miss Sarah O’Dwyer Mr. David Sherlock Mr. Ian Welch Mr. Malcolm Wilson G) – – – – Colorectal/anal chemotherapy and radiotherapy Colorectal chemotherapy and radiotherapy Colorectal chemotherapy and radiotherapy Colorectal/anal chemotherapy and radiotherapy, Gastric Adjuvant Radiotherapy. Pseudomyxoma Colorectal, cholangiocarcinoma, hepatocellular carcinoma, pancreatic cancer neuroendocrine Colorectal Chemotherapy Colorectal Chemotherapy Colorectal chemotherapy Oesphago-Gastric Chemotherapy and Carcinoid Oesphago-Gastric Chemotherapy and Gene /Immunotherapy Research Colorectal and pelvic malignancy Hepatobiliary Surgery Upper GI Surgery Colorectal and pelvic malignancy The proposed appointment The Christie hospital gastrointestinal unit is referred approximately 1200 case per year of which, about 700 are patients with colorectal cancer. We also have a particular interest in rarer tumours such as anal cancer, neuroendocrine tumours and pseudomyxoma peritonei. We work very closely as a gastrointestinal disease orientated group (GI DOG). In total, there are already six medical oncology consultants and four clinical oncology consultants who specialise in GI malignancies within the abdominal cavity. There are also four lower GI surgeons and together we have a number of joint or parallel clinics and multidisciplinary meetings (MDT). The colorectal and pancreatobiliary section of the GI DOG has a separate research unit that holds six research nurses, four data managers, a trials coordinator and clerk. They are essential for the coordination and management of the vast array of clinical trials that we are involved with. We also have two nurse clinicians and two GP clinical assistants that provide valuable help in the busy Christie chemotherapy clinics. We have an active network that coordinates treatment and provides guidelines for patients being managed in the Greater Manchester and Cheshire region. Patients are regularly seen in peripheral units such as Wythenshaw and Leighton Hospitals and simple therapies are often administered locally. The aim is to increase the number of patient treated in these units and also to expand the number of clinical trials available to them. All patients that require radiotherapy are treated within the Christie Hospital. The successful applicant will be based at Christie hospital but will have weekly sessions at both Leighton and Wythenshaw Hospitals. At the former hospital, the post-holder will be required to continue with the clinic and MDT sessions as well as setting up a comprehensive GI chemotherapy service for patients in this region. At Wythenshaw, the post-holder will be expected to collaborate with Dr Mark Saunders and continue to provide a regular clinical session and MDT service at this hospital. The main aim centrally will be to continue to expand the clinical trial service offered at the Christie. There will also be adequate opportunity to collaborate with other investigators within the Christie and also scientists within the Paterson Institute in other areas of GI research. We expect the new appointment to manage a new referral case load of approximately 250 patients a year Management/Audit The appointee will play a full part in clinical audit as a member of the Christie Hospital Medical Staff Committee. New Posts: job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008 7 Continuing Medical Education The Trust supports the requirements for continuing medical education as laid down by the appropriate Royal College and is committed to providing time and financial support for these activities. Proposed PA’s As indicated, this is a new post and 10 PA’s will be offered (7.5 D Direct Clinical Activities and 2.5 Supporting Professional Activities) The prospective candidates will need to discuss their specific clinical interests with both Trusts. This Job Plan is indicative and may evolve as oncology services across the network develop. SERVICE Location Direct Clinical Care Programmed Activity Outpatient clinics/MDTs at Wythenshawe/Leighton Hospitals Ward Rounds, Christie Hospital Radiotherapy simulator, computer planning at Christie Hospital Outpatient clinics at Christie Hospital 3 Clinical trial activity 0.5 – 1 MDT / x-ray meetings at christie 0.5 0.5 1 - 1.5 (if clinical oncologist) 2.5 Supporting professional 2.5 Activities (training, CPD, teaching, audit, clinical governance, appraisal and clinical management) Total 10 (slight variations to cover possibility of CO or MO being appointed) New Posts: job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008 8 H) Indicative Timetable The following is the proposed timetable. Monday ( Christie ) Tuesday ( Christie/Wyth ) Wednesday (Christie) Thursday (Christ/Leightn) Friday (Christie) 8 am pelvic meet (alt wks) 9 am to 1 pm. 50% trials, 50% Service clinic CPD/Admin Ward Round (Christie) Leighton 8 am X.Ray meet (alt wks) MDT Christie CPD/Admin Wythenshaw clinic (alt wks) Weekly MDT and 2 clinics 13:00 to 17:00 Christie Clinic 1 pm seminar 3-5 pm with MDT The post holder will be expected to be on the Consultant on-call for Clinical or Medical Oncology. I) Duties of the Post 1. Main Duties: To be a consultant at the Christie Hospital NHS Foundation Trust. This will involve close liaison with other members of the multidisciplinary team. A major role of this new post will be to develop and implement evidence based best practice for patients treated at Christie, Leighton and SMUH Trust. 2. Clinical Management: To work closely with other medical colleagues in the fields of colorectal cancer. An important role of the consultant will be to have direct involvement in the day-to-day clinical management of patients. This post holder will create a close interface between the laboratory and clinical medicine facilitating the continued development of clinically relevant, evidence-based protocols. 3. Clinics: The post holder would be required support 4 clinics per week. 4. Protocols: The post holder will be expected to revise and develop evidence-based protocols for patients. He/she will be expected to undertake the administrative duties associated with the care of these patients. 5. Professional Development: He/she will maintain a level of continuing professional development consistent with the recommendations of the Royal College of Physicians / Radiologists. Appropriate arrangements for study leave will be made in conjunction with colleagues. A fund, administered by the Clinical Director for the support of study leave, exists within the Trust. The post-holder will also be required to undergo annual appraisal. 6. Teaching Commitment: a) Undergraduate The appointee will be required to contribute to the undergraduate teaching of medical students on clinical topics. The undergraduate teaching commitment will amount at most to the equivalent of around one session per week. b) Postgraduate New Posts: job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008 9 The Unit has a busy postgraduate teaching programme and staff are often requested to lecture on oncology topics. This may amount to one session per month. 7. Junior Doctor Training: The post holder will be expected to contribute actively to the training of Specialty Trainees in oncology. The post holder will also be expected to help in the training of nursing and multi-disciplinary staff in both in-patient and outpatient departments. 8. Clinical Governance: The post-holder will be expected to participate in all relevant aspects of clinical governance, including maintaining up to date protocols, guidelines and clinical audit, under the supervision of the other consultants in the unit. 9. Audit: The appointee will play a full role in clinical audit as a member of the Christie Hospital Medical Staff Committee. 10. Research: There are excellent opportunities for research within the department. The appointee would be encouraged to contribute to current research projects within the department and/or set up new projects. 11. On Call: The post attracts an on call commitment. New Posts: job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008 10 J) PERSON SPECIFICATION REQUIREMENTS Qualifications ESSENTIAL MBBS or equivalent MRCP or FRCR or equivalent Certificate of completion of subspecialty training in either Medical Oncology or Clinical Oncology, or evidence of completion within six months of the date of the Advisory Appointments Committee DESIRABLE Training & Experience Evidence of wide experience of general and oncological medicine Evidence of extensive training in the management of upper GI cancers Demonstrated interest in teaching / education An interest in teaching medical, nursing and allied health professional staff Experience of teaching undergraduate / postgraduate trainees Academic / Research achievements Able to demonstrate continuing research interest and activity Recent articles in peer-reviewed publications MSc, MD or PhD The ability to initiate design and supervise clinical research Personal Skills Clinical leadership and people management skills, with the ability to motivate staff Demonstrable interpersonal skills Evidence of excellent written and oral communication skills Flexible approach to work The ability to work as part of as multi-disciplinary team Good time management skills, with the ability to handle competing demands Personal Circumstances Reliable work record Good health record Living within reasonable travelling distance from the hospital New Posts: job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008 11 TERMS AND CONDITIONS OF SERVICE PAY The salary details for this post will be on the New Consultant Contract Payscale. CONFIDENTIALITY The post-holder must maintain the confidentiality of information about patients, staff and other health service business. HEALTH AND SAFETY Employees must be aware of the responsibilities placed on them under the Health & Safety at Work Act (1974), to ensure that the agreed safety procedures are carried out to maintain a safe environment for employees. RISK MANAGEMENT All staff have a responsibility to report all clinical and non-clinical accidents or incidents promptly and when requested to co-operate with any investigation undertaken. EQUAL OPPORTUNITIES The Trust has adopted an equal opportunities policy and it is the duty of every employee to comply with the detail and spirit of the policy CONFLICT OF INTEREST The Trust is responsible for the service for the patients in its care meets the highest standards. Equally, it is responsible for ensuring that staff do not abuse their official position to gain or to benefit their family or friends. The Trust’s standing orders require any officer to declare any interest, direct or indirect with contracts involving the Trust. Staff are not allowed to further their private interest in the course of their NHS duties. NO SMOKING The Trust operates a no smoking policy. Anyone who wishes to smoke may do so only in one of the designated smoking areas at a time agreed with their line manager. MEDICAL EXAMINATION All appointments with Christie NHS Foundation Trust are subject to pre-employment health screening. K) Informal Visits Interested candidates are encouraged to discuss the post with one or more of the following people. Dr Michael Leahy, Clinical Director for Medical Oncology, may be contacted via his secretary, Gwynneth Mattimore, on 0161 446 8384 or [email protected] Dr Nick Slevin, 0161 446 3361 or [email protected] Dr Mark Saunders, 0161 446 33357 or [email protected] Dr Juan Valle, 0161 446 8106 or [email protected] New Posts: job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008 12 APPENDIX 1 Clinical Oncology Consultant Staff (July 2008) Dr N J Slevin Dr R A Cowan Dr J P Logue Dr P A Burt Dr A Chittalia Dr S E Davidson Dr T Elliott Dr C Faivre-Finn Dr H R Gattamaneni Dr M Harris Prof T Illidge Dr A Jackson Dr L Lee Dr E Levine Dr JE Livsey Dr J Loncaster Dr L Pemberton Dr B Magee Dr V Misra Dr C McBain Prof P Price Dr M Saunders Dr E Smith Dr A L Stewart Breast Dr R Stout Dr A Sykes Dr R S Welch Dr J Wylie Dr B Yap Dr E Allan New Posts: Head and Neck Genito Urinary, Lymphoma Genito Urinary Lung Breast, Lung Gynaecology Urology Lung, oesophageal Children/Young Adult/CNS Lung/Lymphoma Lymphoma Upper GI Head and neck, Lung Gastro Intestinal Gynaecology/urology Breast, PDT for skin cancer Lung Breast cancer Breast, Colorectal Colorectal, CNS Upper GI Gastrointestinal Lymphoma, Paediatric/Young Adult Lung Head & Neck/Melanoma Ovarian Cancer, Testicularcancer, Breast cancer Genito-urinary, Soft Tissue Sarcoma Thyroid/Head & Neck PDT for skin cancer job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008 13 APPENDIX 2 Medical Oncology Consultant Staff (July 2008) Prof R Hawkins Prof A Howell Prof G Jayson Dr P Lorigan Prof J Radford Prof M Ranson Prof N Thatcher Dr F Blackhall Dr J Valle Dr A Wardley Dr G Wilson Dr J Hassan Dr M Leahy Dr W Mansoor Dr S Mullamitha Dr A Armstrong Dr A Clamp Dr F Thistlethwaite New Posts: Renal, Gastric and Immunotherapy Phase I Trials Breast cancer prevention Ovarian Cancer and Anti-Angiogenesis Phase I Trials Melanoma and Lung Cancer Lymphoma Clinical Pharmacology and Lung Cancer Lung Cancer Lung Cancer Colorectal, Pancreatic Cancer Breast Cancer Breast and Colorectal Cancer Colorectal and Ovarian Sarcoma and Teratoma Upper GI and Carcinoid Lower GI – link with Oldham Breast Cancer Ovarian and Gynaecological Oncology Upper GI job descriptions & job plans lower GI- Christie, Leighton and SMUHT July 2008 14